Kamille Dumong Erichsen

Antisense‐mediated reduction of proprotein convertase subtilisin/kexin type 9 (PCSK9): a first‐in‐human randomized, placebo‐controlled trial

Eveline P. van Poelgeest, Michael R. Hodges, Matthijs Moerland et al. · British Journal of Clinical Pharmacology · 2015 · 89 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +16

Antisense oligonucleotide treatment rescues UBE3A expression and multiple phenotypes of an Angelman syndrome mouse model

Claudia Milazzo, Edwin Mientjes, Ilse Wallaard et al. · JCI Insight · 2021 · 86 citations · Full text

Life Sciences, Genetics, Neuroscience +14

Synthesis and Antitumor Effect in Vitro and in Vivo of Substituted 1,3-Dihydroindole-2-ones

Mette Krogh Christensen, Kamille Dumong Erichsen, Christina Trojel‐Hansen et al. · Journal of Medicinal Chemistry · 2010 · 75 citations

Pharmacy, Medicinal Chemistry, Pharmacology +13

Nicotinamide Phosphoribosyltransferase Inhibitors, Design, Preparation, and Structure–Activity Relationship

Mette Krogh Christensen, Kamille Dumong Erichsen, Uffe H. Olesen et al. · Journal of Medicinal Chemistry · 2013 · 39 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +15

Early Detection of Response to Experimental Chemotherapeutic Top216 with [18F]FLT and [18F]FDG PET in Human Ovary Cancer Xenografts in Mice

Mette Munk Jensen, Kamille Dumong Erichsen, Fredrik Björkling et al. · PLoS ONE · 2010 · 37 citations · Full text

Medicine, Nuclear Medicine, Oncology +15